喘息緩和薬（レスキュー薬）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Asthma Reliever (Rescue) Medications Market Insights, Forecast to 2028

• レポートコード：QY2207E10363 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の喘息緩和薬（レスキュー薬）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に喘息緩和薬（レスキュー薬）の世界市場のxxx％を占める「即効性医薬品」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「子供用」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の喘息緩和薬（レスキュー薬）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの喘息緩和薬（レスキュー薬）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの喘息緩和薬（レスキュー薬）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 喘息緩和薬（レスキュー薬）のグローバル主要メーカーには、Dulera、QVAR、Glaxosmithkline plc、MAP Pharmaceuticals，Inc、Merck & Co. Inc、AstraZeneca plc、Roche Holdings Ltd、Genentech Inc、Sepracor, Inc、Schering-Plough Corp、Sanofi-Aventis、Theravance Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 喘息緩和薬（レスキュー薬）市場は、種類と用途によって区分されます。世界の喘息緩和薬（レスキュー薬）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 即効性医薬品、長期管理医薬品 【用途別セグメント】 子供用、青少年用、大人用 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 喘息緩和薬（レスキュー薬）製品概要 - 種類別市場（即効性医薬品、長期管理医薬品） - 用途別市場（子供用、青少年用、大人用） - 調査の目的 ・エグゼクティブサマリー - 世界の喘息緩和薬（レスキュー薬）販売量予測2017-2028 - 世界の喘息緩和薬（レスキュー薬）売上予測2017-2028 - 喘息緩和薬（レスキュー薬）の地域別販売量 - 喘息緩和薬（レスキュー薬）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別喘息緩和薬（レスキュー薬）販売量 - 主要メーカー別喘息緩和薬（レスキュー薬）売上 - 主要メーカー別喘息緩和薬（レスキュー薬）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（即効性医薬品、長期管理医薬品） - 喘息緩和薬（レスキュー薬）の種類別販売量 - 喘息緩和薬（レスキュー薬）の種類別売上 - 喘息緩和薬（レスキュー薬）の種類別価格 ・用途別市場規模（子供用、青少年用、大人用） - 喘息緩和薬（レスキュー薬）の用途別販売量 - 喘息緩和薬（レスキュー薬）の用途別売上 - 喘息緩和薬（レスキュー薬）の用途別価格 ・北米市場 - 北米の喘息緩和薬（レスキュー薬）市場規模（種類別、用途別） - 主要国別の喘息緩和薬（レスキュー薬）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの喘息緩和薬（レスキュー薬）市場規模（種類別、用途別） - 主要国別の喘息緩和薬（レスキュー薬）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の喘息緩和薬（レスキュー薬）市場規模（種類別、用途別） - 主要国別の喘息緩和薬（レスキュー薬）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の喘息緩和薬（レスキュー薬）市場規模（種類別、用途別） - 主要国別の喘息緩和薬（レスキュー薬）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの喘息緩和薬（レスキュー薬）市場規模（種類別、用途別） - 主要国別の喘息緩和薬（レスキュー薬）市場規模（トルコ、サウジアラビア） ・企業情報 Dulera、QVAR、Glaxosmithkline plc、MAP Pharmaceuticals，Inc、Merck & Co. Inc、AstraZeneca plc、Roche Holdings Ltd、Genentech Inc、Sepracor, Inc、Schering-Plough Corp、Sanofi-Aventis、Theravance Inc ・産業チェーン及び販売チャネル分析 - 喘息緩和薬（レスキュー薬）の産業チェーン分析 - 喘息緩和薬（レスキュー薬）の原材料 - 喘息緩和薬（レスキュー薬）の生産プロセス - 喘息緩和薬（レスキュー薬）の販売及びマーケティング - 喘息緩和薬（レスキュー薬）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 喘息緩和薬（レスキュー薬）の産業動向 - 喘息緩和薬（レスキュー薬）のマーケットドライバー - 喘息緩和薬（レスキュー薬）の課題 - 喘息緩和薬（レスキュー薬）の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Asthma Reliever (Rescue) Medications Market
Due to the COVID-19 pandemic, the global Asthma Reliever (Rescue) Medications market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Quick-Relief Medications accounting for % of the Asthma Reliever (Rescue) Medications global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Children segment is altered to an % CAGR throughout this forecast period.
China Asthma Reliever (Rescue) Medications market size is valued at US$ million in 2021, while the US and Europe Asthma Reliever (Rescue) Medications are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Asthma Reliever (Rescue) Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Asthma Reliever (Rescue) Medications include Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc and Sepracor, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Asthma Reliever (Rescue) Medications Scope and Segment
Asthma Reliever (Rescue) Medications market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Asthma Reliever (Rescue) Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Quick-Relief Medications
Long-Term Control Medications
Segment by Application
Children
Adolescent
Adult
By Company
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals，Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Asthma Reliever (Rescue) Medications Product Introduction
1.2 Market by Type
1.2.1 Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.3 Market by Application
1.3.1 Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Asthma Reliever (Rescue) Medications Sales Estimates and Forecasts 2017-2028
2.2 Global Asthma Reliever (Rescue) Medications Revenue Estimates and Forecasts 2017-2028
2.3 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Asthma Reliever (Rescue) Medications Sales by Region
2.4.1 Global Asthma Reliever (Rescue) Medications Sales by Region (2017-2022)
2.4.2 Global Sales Asthma Reliever (Rescue) Medications by Region (2023-2028)
2.5 Global Asthma Reliever (Rescue) Medications Revenue by Region
2.5.1 Global Asthma Reliever (Rescue) Medications Revenue by Region (2017-2022)
2.5.2 Global Asthma Reliever (Rescue) Medications Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Asthma Reliever (Rescue) Medications Sales by Manufacturers
3.1.1 Global Top Asthma Reliever (Rescue) Medications Manufacturers by Sales (2017-2022)
3.1.2 Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Asthma Reliever (Rescue) Medications in 2021
3.2 Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers
3.2.1 Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers (2017-2022)
3.2.2 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Asthma Reliever (Rescue) Medications Revenue in 2021
3.3 Global Asthma Reliever (Rescue) Medications Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Asthma Reliever (Rescue) Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Asthma Reliever (Rescue) Medications Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Asthma Reliever (Rescue) Medications Sales by Type
4.1.1 Global Asthma Reliever (Rescue) Medications Historical Sales by Type (2017-2022)
4.1.2 Global Asthma Reliever (Rescue) Medications Forecasted Sales by Type (2023-2028)
4.1.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2028)
4.2 Global Asthma Reliever (Rescue) Medications Revenue by Type
4.2.1 Global Asthma Reliever (Rescue) Medications Historical Revenue by Type (2017-2022)
4.2.2 Global Asthma Reliever (Rescue) Medications Forecasted Revenue by Type (2023-2028)
4.2.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2028)
4.3 Global Asthma Reliever (Rescue) Medications Price by Type
4.3.1 Global Asthma Reliever (Rescue) Medications Price by Type (2017-2022)
4.3.2 Global Asthma Reliever (Rescue) Medications Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Asthma Reliever (Rescue) Medications Sales by Application
5.1.1 Global Asthma Reliever (Rescue) Medications Historical Sales by Application (2017-2022)
5.1.2 Global Asthma Reliever (Rescue) Medications Forecasted Sales by Application (2023-2028)
5.1.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2028)
5.2 Global Asthma Reliever (Rescue) Medications Revenue by Application
5.2.1 Global Asthma Reliever (Rescue) Medications Historical Revenue by Application (2017-2022)
5.2.2 Global Asthma Reliever (Rescue) Medications Forecasted Revenue by Application (2023-2028)
5.2.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2028)
5.3 Global Asthma Reliever (Rescue) Medications Price by Application
5.3.1 Global Asthma Reliever (Rescue) Medications Price by Application (2017-2022)
5.3.2 Global Asthma Reliever (Rescue) Medications Price Forecast by Application (2023-2028)
6 North America
6.1 North America Asthma Reliever (Rescue) Medications Market Size by Type
6.1.1 North America Asthma Reliever (Rescue) Medications Sales by Type (2017-2028)
6.1.2 North America Asthma Reliever (Rescue) Medications Revenue by Type (2017-2028)
6.2 North America Asthma Reliever (Rescue) Medications Market Size by Application
6.2.1 North America Asthma Reliever (Rescue) Medications Sales by Application (2017-2028)
6.2.2 North America Asthma Reliever (Rescue) Medications Revenue by Application (2017-2028)
6.3 North America Asthma Reliever (Rescue) Medications Market Size by Country
6.3.1 North America Asthma Reliever (Rescue) Medications Sales by Country (2017-2028)
6.3.2 North America Asthma Reliever (Rescue) Medications Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Asthma Reliever (Rescue) Medications Market Size by Type
7.1.1 Europe Asthma Reliever (Rescue) Medications Sales by Type (2017-2028)
7.1.2 Europe Asthma Reliever (Rescue) Medications Revenue by Type (2017-2028)
7.2 Europe Asthma Reliever (Rescue) Medications Market Size by Application
7.2.1 Europe Asthma Reliever (Rescue) Medications Sales by Application (2017-2028)
7.2.2 Europe Asthma Reliever (Rescue) Medications Revenue by Application (2017-2028)
7.3 Europe Asthma Reliever (Rescue) Medications Market Size by Country
7.3.1 Europe Asthma Reliever (Rescue) Medications Sales by Country (2017-2028)
7.3.2 Europe Asthma Reliever (Rescue) Medications Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Asthma Reliever (Rescue) Medications Market Size by Type
8.1.1 Asia Pacific Asthma Reliever (Rescue) Medications Sales by Type (2017-2028)
8.1.2 Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Type (2017-2028)
8.2 Asia Pacific Asthma Reliever (Rescue) Medications Market Size by Application
8.2.1 Asia Pacific Asthma Reliever (Rescue) Medications Sales by Application (2017-2028)
8.2.2 Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Application (2017-2028)
8.3 Asia Pacific Asthma Reliever (Rescue) Medications Market Size by Region
8.3.1 Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2017-2028)
8.3.2 Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Asthma Reliever (Rescue) Medications Market Size by Type
9.1.1 Latin America Asthma Reliever (Rescue) Medications Sales by Type (2017-2028)
9.1.2 Latin America Asthma Reliever (Rescue) Medications Revenue by Type (2017-2028)
9.2 Latin America Asthma Reliever (Rescue) Medications Market Size by Application
9.2.1 Latin America Asthma Reliever (Rescue) Medications Sales by Application (2017-2028)
9.2.2 Latin America Asthma Reliever (Rescue) Medications Revenue by Application (2017-2028)
9.3 Latin America Asthma Reliever (Rescue) Medications Market Size by Country
9.3.1 Latin America Asthma Reliever (Rescue) Medications Sales by Country (2017-2028)
9.3.2 Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Asthma Reliever (Rescue) Medications Market Size by Type
10.1.1 Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Type (2017-2028)
10.1.2 Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Type (2017-2028)
10.2 Middle East and Africa Asthma Reliever (Rescue) Medications Market Size by Application
10.2.1 Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Application (2017-2028)
10.2.2 Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Application (2017-2028)
10.3 Middle East and Africa Asthma Reliever (Rescue) Medications Market Size by Country
10.3.1 Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2017-2028)
10.3.2 Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Dulera
11.1.1 Dulera Corporation Information
11.1.2 Dulera Overview
11.1.3 Dulera Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Dulera Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Dulera Recent Developments
11.2 QVAR
11.2.1 QVAR Corporation Information
11.2.2 QVAR Overview
11.2.3 QVAR Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 QVAR Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 QVAR Recent Developments
11.3 Glaxosmithkline plc
11.3.1 Glaxosmithkline plc Corporation Information
11.3.2 Glaxosmithkline plc Overview
11.3.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Glaxosmithkline plc Recent Developments
11.4 MAP Pharmaceuticals，Inc
11.4.1 MAP Pharmaceuticals，Inc Corporation Information
11.4.2 MAP Pharmaceuticals，Inc Overview
11.4.3 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MAP Pharmaceuticals，Inc Recent Developments
11.5 Merck & Co. Inc
11.5.1 Merck & Co. Inc Corporation Information
11.5.2 Merck & Co. Inc Overview
11.5.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck & Co. Inc Recent Developments
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Corporation Information
11.6.2 AstraZeneca plc Overview
11.6.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AstraZeneca plc Recent Developments
11.7 Roche Holdings Ltd
11.7.1 Roche Holdings Ltd Corporation Information
11.7.2 Roche Holdings Ltd Overview
11.7.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Roche Holdings Ltd Recent Developments
11.8 Genentech Inc
11.8.1 Genentech Inc Corporation Information
11.8.2 Genentech Inc Overview
11.8.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Genentech Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genentech Inc Recent Developments
11.9 Sepracor, Inc
11.9.1 Sepracor, Inc Corporation Information
11.9.2 Sepracor, Inc Overview
11.9.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sepracor, Inc Recent Developments
11.10 Schering-Plough Corp
11.10.1 Schering-Plough Corp Corporation Information
11.10.2 Schering-Plough Corp Overview
11.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Schering-Plough Corp Recent Developments
11.11 Sanofi-Aventis
11.11.1 Sanofi-Aventis Corporation Information
11.11.2 Sanofi-Aventis Overview
11.11.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sanofi-Aventis Recent Developments
11.12 Theravance Inc
11.12.1 Theravance Inc Corporation Information
11.12.2 Theravance Inc Overview
11.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Theravance Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Asthma Reliever (Rescue) Medications Industry Chain Analysis
12.2 Asthma Reliever (Rescue) Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Asthma Reliever (Rescue) Medications Production Mode & Process
12.4 Asthma Reliever (Rescue) Medications Sales and Marketing
12.4.1 Asthma Reliever (Rescue) Medications Sales Channels
12.4.2 Asthma Reliever (Rescue) Medications Distributors
12.5 Asthma Reliever (Rescue) Medications Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Asthma Reliever (Rescue) Medications Industry Trends
13.2 Asthma Reliever (Rescue) Medications Market Drivers
13.3 Asthma Reliever (Rescue) Medications Market Challenges
13.4 Asthma Reliever (Rescue) Medications Market Restraints
14 Key Findings in The Global Asthma Reliever (Rescue) Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Quick-Relief Medications
Table 3. Major Manufacturers of Long-Term Control Medications
Table 4. Global Asthma Reliever (Rescue) Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Asthma Reliever (Rescue) Medications Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Asthma Reliever (Rescue) Medications Sales by Region (2017-2022) & (K Units)
Table 7. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2017-2022)
Table 8. Global Asthma Reliever (Rescue) Medications Sales by Region (2023-2028) & (K Units)
Table 9. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2023-2028)
Table 10. Global Asthma Reliever (Rescue) Medications Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2017-2022)
Table 12. Global Asthma Reliever (Rescue) Medications Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2023-2028)
Table 14. Global Asthma Reliever (Rescue) Medications Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Asthma Reliever (Rescue) Medications Sales Share by Manufacturers (2017-2022)
Table 16. Global Asthma Reliever (Rescue) Medications Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Asthma Reliever (Rescue) Medications Revenue Share by Manufacturers (2017-2022)
Table 18. Asthma Reliever (Rescue) Medications Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Asthma Reliever (Rescue) Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Asthma Reliever (Rescue) Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Reliever (Rescue) Medications as of 2021)
Table 21. Asthma Reliever (Rescue) Medications Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Asthma Reliever (Rescue) Medications Product Offered
Table 23. Date of Manufacturers Enter into Asthma Reliever (Rescue) Medications Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)
Table 26. Global Asthma Reliever (Rescue) Medications Sales by Type (2023-2028) & (K Units)
Table 27. Global Asthma Reliever (Rescue) Medications Sales Share by Type (2017-2022)
Table 28. Global Asthma Reliever (Rescue) Medications Sales Share by Type (2023-2028)
Table 29. Global Asthma Reliever (Rescue) Medications Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Asthma Reliever (Rescue) Medications Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Asthma Reliever (Rescue) Medications Revenue Share by Type (2017-2022)
Table 32. Global Asthma Reliever (Rescue) Medications Revenue Share by Type (2023-2028)
Table 33. Asthma Reliever (Rescue) Medications Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Asthma Reliever (Rescue) Medications Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)
Table 36. Global Asthma Reliever (Rescue) Medications Sales by Application (2023-2028) & (K Units)
Table 37. Global Asthma Reliever (Rescue) Medications Sales Share by Application (2017-2022)
Table 38. Global Asthma Reliever (Rescue) Medications Sales Share by Application (2023-2028)
Table 39. Global Asthma Reliever (Rescue) Medications Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Asthma Reliever (Rescue) Medications Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Asthma Reliever (Rescue) Medications Revenue Share by Application (2017-2022)
Table 42. Global Asthma Reliever (Rescue) Medications Revenue Share by Application (2023-2028)
Table 43. Asthma Reliever (Rescue) Medications Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Asthma Reliever (Rescue) Medications Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)
Table 46. North America Asthma Reliever (Rescue) Medications Sales by Type (2023-2028) & (K Units)
Table 47. North America Asthma Reliever (Rescue) Medications Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Asthma Reliever (Rescue) Medications Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)
Table 50. North America Asthma Reliever (Rescue) Medications Sales by Application (2023-2028) & (K Units)
Table 51. North America Asthma Reliever (Rescue) Medications Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Asthma Reliever (Rescue) Medications Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Asthma Reliever (Rescue) Medications Sales by Country (2017-2022) & (K Units)
Table 54. North America Asthma Reliever (Rescue) Medications Sales by Country (2023-2028) & (K Units)
Table 55. North America Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Asthma Reliever (Rescue) Medications Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)
Table 58. Europe Asthma Reliever (Rescue) Medications Sales by Type (2023-2028) & (K Units)
Table 59. Europe Asthma Reliever (Rescue) Medications Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Asthma Reliever (Rescue) Medications Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)
Table 62. Europe Asthma Reliever (Rescue) Medications Sales by Application (2023-2028) & (K Units)
Table 63. Europe Asthma Reliever (Rescue) Medications Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Asthma Reliever (Rescue) Medications Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Asthma Reliever (Rescue) Medications Sales by Country (2017-2022) & (K Units)
Table 66. Europe Asthma Reliever (Rescue) Medications Sales by Country (2023-2028) & (K Units)
Table 67. Europe Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Asthma Reliever (Rescue) Medications Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Asthma Reliever (Rescue) Medications Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Asthma Reliever (Rescue) Medications Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Asthma Reliever (Rescue) Medications Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Asthma Reliever (Rescue) Medications Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Asthma Reliever (Rescue) Medications Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Asthma Reliever (Rescue) Medications Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Asthma Reliever (Rescue) Medications Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Asthma Reliever (Rescue) Medications Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2023-2028) & (US$ Million)
Table 105. Dulera Corporation Information
Table 106. Dulera Description and Major Businesses
Table 107. Dulera Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Dulera Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Dulera Recent Developments
Table 110. QVAR Corporation Information
Table 111. QVAR Description and Major Businesses
Table 112. QVAR Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. QVAR Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. QVAR Recent Developments
Table 115. Glaxosmithkline plc Corporation Information
Table 116. Glaxosmithkline plc Description and Major Businesses
Table 117. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Glaxosmithkline plc Recent Developments
Table 120. MAP Pharmaceuticals，Inc Corporation Information
Table 121. MAP Pharmaceuticals，Inc Description and Major Businesses
Table 122. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. MAP Pharmaceuticals，Inc Recent Developments
Table 125. Merck & Co. Inc Corporation Information
Table 126. Merck & Co. Inc Description and Major Businesses
Table 127. Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Merck & Co. Inc Recent Developments
Table 130. AstraZeneca plc Corporation Information
Table 131. AstraZeneca plc Description and Major Businesses
Table 132. AstraZeneca plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. AstraZeneca plc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. AstraZeneca plc Recent Developments
Table 135. Roche Holdings Ltd Corporation Information
Table 136. Roche Holdings Ltd Description and Major Businesses
Table 137. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Roche Holdings Ltd Recent Developments
Table 140. Genentech Inc Corporation Information
Table 141. Genentech Inc Description and Major Businesses
Table 142. Genentech Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Genentech Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Genentech Inc Recent Developments
Table 145. Sepracor, Inc Corporation Information
Table 146. Sepracor, Inc Description and Major Businesses
Table 147. Sepracor, Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Sepracor, Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Sepracor, Inc Recent Developments
Table 150. Schering-Plough Corp Corporation Information
Table 151. Schering-Plough Corp Description and Major Businesses
Table 152. Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Schering-Plough Corp Recent Developments
Table 155. Sanofi-Aventis Corporation Information
Table 156. Sanofi-Aventis Description and Major Businesses
Table 157. Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Sanofi-Aventis Recent Developments
Table 160. Theravance Inc Corporation Information
Table 161. Theravance Inc Description and Major Businesses
Table 162. Theravance Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Theravance Inc Asthma Reliever (Rescue) Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Theravance Inc Recent Developments
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Asthma Reliever (Rescue) Medications Distributors List
Table 168. Asthma Reliever (Rescue) Medications Customers List
Table 169. Asthma Reliever (Rescue) Medications Market Trends
Table 170. Asthma Reliever (Rescue) Medications Market Drivers
Table 171. Asthma Reliever (Rescue) Medications Market Challenges
Table 172. Asthma Reliever (Rescue) Medications Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Asthma Reliever (Rescue) Medications Product Picture
Figure 3. Global Asthma Reliever (Rescue) Medications Market Share by Type in 2021 & 2028
Figure 3. Quick-Relief Medications Product Picture
Figure 4. Long-Term Control Medications Product Picture
Figure 5. Global Asthma Reliever (Rescue) Medications Market Share by Application in 2021 & 2028
Figure 6. Children
Figure 7. Adolescent
Figure 8. Adult
Figure 9. Asthma Reliever (Rescue) Medications Report Years Considered
Figure 10. Global Asthma Reliever (Rescue) Medications Sales 2017-2028 (K Units)
Figure 11. Global Asthma Reliever (Rescue) Medications Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Asthma Reliever (Rescue) Medications Revenue 2017-2028 (US$ Million)
Figure 13. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2017-2022)
Figure 15. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2023-2028)
Figure 16. North America Asthma Reliever (Rescue) Medications Sales YoY (2017-2028) & (K Units)
Figure 17. North America Asthma Reliever (Rescue) Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Asthma Reliever (Rescue) Medications Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Asthma Reliever (Rescue) Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Asthma Reliever (Rescue) Medications Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Asthma Reliever (Rescue) Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Asthma Reliever (Rescue) Medications Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Asthma Reliever (Rescue) Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Asthma Reliever (Rescue) Medications Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Asthma Reliever (Rescue) Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Asthma Reliever (Rescue) Medications in the World: Market Share by Asthma Reliever (Rescue) Medications Revenue in 2021
Figure 28. Global Asthma Reliever (Rescue) Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2028)
Figure 30. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2028)
Figure 31. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2028)
Figure 32. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2028)
Figure 33. North America Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2028)
Figure 34. North America Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2028)
Figure 35. North America Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2028)
Figure 36. North America Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2028)
Figure 37. North America Asthma Reliever (Rescue) Medications Sales Share by Country (2017-2028)
Figure 38. North America Asthma Reliever (Rescue) Medications Revenue Share by Country (2017-2028)
Figure 39. United States Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2028)
Figure 42. Europe Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2028)
Figure 43. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2028)
Figure 44. Europe Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2028)
Figure 45. Europe Asthma Reliever (Rescue) Medications Sales Share by Country (2017-2028)
Figure 46. Europe Asthma Reliever (Rescue) Medications Revenue Share by Country (2017-2028)
Figure 47. Germany Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 48. France Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Asthma Reliever (Rescue) Medications Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Asthma Reliever (Rescue) Medications Revenue Share by Region (2017-2028)
Figure 58. China Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 61. India Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2028)
Figure 68. Latin America Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2028)
Figure 70. Latin America Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Asthma Reliever (Rescue) Medications Sales Share by Country (2017-2028)
Figure 72. Latin America Asthma Reliever (Rescue) Medications Revenue Share by Country (2017-2028)
Figure 73. Mexico Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Asthma Reliever (Rescue) Medications Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Asthma Reliever (Rescue) Medications Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Asthma Reliever (Rescue) Medications Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Asthma Reliever (Rescue) Medications Revenue Share by Country (2017-2028)
Figure 82. Turkey Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Asthma Reliever (Rescue) Medications Revenue (2017-2028) & (US$ Million)
Figure 85. Asthma Reliever (Rescue) Medications Value Chain
Figure 86. Asthma Reliever (Rescue) Medications Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

---